FDA Recalls Irinotecan Hydrochloride Injection Due to Incorrect Formulation Calculation
West-Ward Pharmaceutical Corp. is recalling Irinotecan Hydrochloride Injection because an incorrect calculation resulted in an assay higher than the labeled claim.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a superpotent drug with an incorrect formulation calculation resulting in an assay higher than the labeled claim, which meets the criteria for a Severe rating.
Plain-English summary
West-Ward Pharmaceutical Corp. is recalling 9,813 vials of Irinotecan Hydrochloride Injection, 100 mg/5 mL (20 mg/mL), single-dose vials. The affected product is distributed nationwide and includes lots AC0026 and AC0027 with an expiration date of 10/14. The product is manufactured by Thymoorgan Pharmazie GmbH in Germany and distributed by West-Ward Pharmaceutical Corp. in Eatontown, NJ.
The recall was initiated because a recent review of the United States Pharmacopeia (USP) revealed that an incorrect calculation was used to determine the amount of irinotecan used in the formulation. This error results in an assay that is higher than the labeled claim. Irinotecan is classified as a superpotent drug.
Healthcare providers and patients should stop using the affected vials and contact West-Ward Pharmaceutical Corp. for further instructions or to arrange for a return or replacement. The recall is classified as Class II by the FDA.
The recalled product
- Product
- IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)
- Brand
- IRINOTECAN HYDROCHLORIDE
- Manufacturer
- West-Ward Pharmaceutical Corp.
- Category
- Drug — Injection
- Affected units
- 9,813
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: AC0026
- AC0027
- Exp 10/14
UPCs (1)
- 0301439701019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by West-Ward Pharmaceutical Corp. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · IRINOTECAN HYDROCHLORIDE
- ModerateHikma Recalls Irinotecan Hydrochloride Injection Due to Container Defect
FDA (Drugs) · 2020-06-24
- ModerateHikma Recalls Irinotecan Hydrochloride Vials Due to Container Defect
FDA (Drugs) · 2020-06-24
- SevereIngenus Recalls Irinotecan Hydrochloride Injection Due to Potency Issues
FDA (Drugs) · 2018-07-11
- SevereIngenus Recalls Irinotecan Hydrochloride Injection Due to Potency Issues
FDA (Drugs) · 2018-07-11
- SevereIrinotecan Hydrochloride Injection Recalled for Incorrect Formulation Calculation
FDA (Drugs) · 2013-11-13
Same manufacturer · West-Ward Pharmaceutical Corp.
See all →- ModerateWest-Ward Recalls Fentanyl Citrate Injection Due to Impurity Failures
FDA (Drugs) · 2015-06-24
- ModerateWest-Ward Recalls Ethambutol Hydrochloride Tablets Due to Stability Failure
FDA (Drugs) · 2014-11-05
- ModerateWest-Ward Recalls Isoniazid Tablets Due to Dissolution Failure
FDA (Drugs) · 2014-07-09
- SevereWest-Ward Recalls Carisoprodol Tablets Due to Foreign Substance Presence
FDA (Drugs) · 2013-12-25
- ModerateWest-Ward Recalls Belladonna Alkaloids Tablets Due to Foreign Substance
FDA (Drugs) · 2013-08-21
Same hazard · incorrect formulation
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereTPN Bag Recalled for Missing Insulin Formulation Error
FDA (Drugs) · 2026-05-13
- ModerateCompounded ophthalmic syringes recalled over an incorrect product formulation
FDA (Drugs) · 2025-12-17
- ModerateTadalafil Tablets Recalled Due to Incorrect Product Formulation
FDA (Drugs) · 2021-11-17